FDA to review Bronchitol for CF

FDA accepted for review an NDA from Pharmaxis Ltd. (ASX:PXS; Pink:PXSLY) for Bronchitol mannitol to treat cystic fibrosis (CF) in patients six years of age or older to improve pulmonary function. The PDUFA date is March 18, 2013. ...